A Study of Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C

NCT01482403 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: Copegus
DRUG: Copegus
DRUG: Pegasys
DRUG: Pegasys
DRUG: boceprevir
DRUG: boceprevir
DRUG: mericitabine
DRUG: mericitabine placebo
DRUG: boceprevir placebo
DRUG: boceprevir

Sponsor

Hoffmann-La Roche